← All Lists
symptoms · 9 items · 1 min read

9 Facts About Menopause and Increased Kidney Stone Risk

Rose
A note from Rose

Nobody warned me that the same hormonal shift causing hot flashes was quietly changing what my kidneys were doing with calcium. The first time a friend described passing a kidney stone at 54 — having never had one before in her life — and her doctor shrugged and called it 'just one of those things,' I went digging. What I found was a clear, physiological story that women absolutely deserve to hear before the pain starts, not after.

Learn more about Rose →
Kidney stones are not the first thing most women associate with menopause — but the hormonal shifts of perimenopause and postmenopause create real, measurable changes in how the kidneys handle calcium, oxalate, and urine chemistry. Research consistently shows postmenopausal women face a meaningfully higher risk of developing stones than their premenopausal selves, yet this connection rarely comes up in routine care. These nine facts lay out exactly what is happening and why it matters.
1

Estrogen actively protects kidney function in ways that go beyond reproduction

Estrogen receptors are present in kidney tissue, and estrogen plays a direct role in regulating how the kidneys filter and excrete calcium, citrate, and oxalate — three key players in stone formation. When estrogen levels fall during perimenopause, this regulatory influence weakens, shifting urine chemistry in directions that favor crystal formation. This is not a minor side effect; it is a structural change in how the urinary system operates.

Grade B — Moderate evidence
2

Postmenopausal women excrete more calcium in their urine

Studies measuring 24-hour urine samples in pre- versus postmenopausal women consistently find higher urinary calcium excretion after menopause — a condition called hypercalciuria. Excess calcium in urine is one of the most significant modifiable risk factors for calcium oxalate stones, the most common type. This shift happens not because women are consuming more calcium, but because estrogen loss disrupts the kidneys' reabsorption of calcium back into the bloodstream.

Grade A — Strong evidence
3

Urinary citrate — the body's natural stone inhibitor — drops after menopause

Citrate binds to calcium in the urine, preventing it from combining with oxalate or phosphate to form crystals. Estrogen appears to promote citrate excretion, so as estrogen falls, citrate levels in urine tend to fall with it. Lower citrate means less natural protection against stone formation, even when calcium levels remain the same — a double hit that most women are never told about.

Grade B — Moderate evidence
4

The overall rate of kidney stones in women rises sharply after menopause

Historically, kidney stones were considered a predominantly male problem, but the gender gap has narrowed significantly in recent decades, with postmenopausal women driving much of that shift. Large epidemiological studies show the incidence rate in women increases after age 50 in a pattern that closely tracks the timing of menopause. By the time women reach their 60s, their stone risk has converged much closer to that of men the same age.

Grade A — Strong evidence
5

Calcium supplements taken without food can make things worse

Many postmenopausal women are advised to take calcium supplements to protect bone density — which is entirely reasonable — but how and when those supplements are taken matters enormously for kidney stone risk. Calcium taken away from meals does not bind dietary oxalate in the gut, allowing more oxalate to be absorbed into the bloodstream and then excreted by the kidneys, raising stone risk. Taking calcium supplements with meals reduces this effect by binding oxalate right where it is absorbed.

Grade A — Strong evidence
6

Dehydration risk increases in menopause and compounds the stone problem

Hot flashes and night sweats cause fluid loss that many women do not fully compensate for, and research suggests thirst sensation can become less reliable with age. Concentrated urine gives minerals less room to stay dissolved, dramatically increasing the likelihood that crystals will form and grow. Adequate hydration — producing pale yellow urine consistently throughout the day — remains one of the most evidence-supported strategies for reducing kidney stone recurrence.

Grade A — Strong evidence
7

Menopausal hormone therapy appears to offer some protection against stones

Several observational studies have found that women using estrogen-based hormone therapy have lower rates of kidney stone formation than those who do not, consistent with estrogen's known role in regulating urinary calcium and citrate. The evidence is not strong enough to recommend hormone therapy solely for kidney stone prevention, but it is one more piece of the overall picture when women and their doctors weigh the risks and benefits of HRT. Women already considering hormone therapy for other menopause symptoms may find this an additional point worth discussing.

Grade B — Moderate evidence
8

High animal protein intake accelerates urinary calcium and uric acid loss

Diets high in animal protein increase the acid load in the body, which the kidneys respond to partly by releasing calcium from bone and excreting it in urine — a process that is already more pronounced in postmenopausal women due to estrogen loss. High protein intake also raises urinary uric acid, which can seed calcium oxalate stones as well as form uric acid stones directly. This does not mean women need to avoid protein, but moderating red meat and processed meat intake has real urological rationale for this group.

Grade A — Strong evidence
9

A one-time urine collection test can reveal personal stone risk before the first stone forms

A 24-hour urine collection — a test that measures calcium, oxalate, citrate, uric acid, and urine volume in a full day's output — can identify exactly which risk factors are elevated in an individual woman before any stone has caused pain. This test is underutilized in primary care but is widely available and particularly worth requesting by postmenopausal women with a family history of stones, known low bone density, or a diet high in oxalate-rich foods. Knowing the specific chemistry driving risk allows for targeted, evidence-based dietary and medical intervention rather than generic advice.

Grade B — Moderate evidence

Want to go deeper?

Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.

Rose
Meet Rose

Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.

Sharing is caring 💕 If this list helped you feel a little less alone, consider passing Rose along to a friend who might need honest answers too.